Cedric Raoul completed his Ph.D. degree at the Developmental Biology Institute of Marseille Luminy, France in 2002. During this period, he focused on the contribution of Fas death receptor in the pathological death of motoneurons (J cell biol, Neuron). He broadened his training to work on gene therapy for amyotrophic lateral sclerosis (ALS) at the Swiss Federal Institute of Technology of Lausanne (EPFL), Switzerland (Nat Med, PNAS, Gene Ther). In 2007, he was appointed to an Inserm Research Associate position and led during five years an Inserm-AVENIR Team in ALS field at the Mediterranean Institute of Neurobiology, Marseille, France (Cell death diff, j neurosci, ann neurol, PLoS one). He is currently leading a research group at the Neuroscience Institute of Montpellier, Inserm UMR1051, Saint Eloi Hospital, Montpellier, France on the neuroinflammatory aspects of ALS. His expertise areas include motoneuron, amyotrophic lateral sclerosis, death receptor signaling, programmed cell death, neuroinflammation, gene therapy, and immunotherapy.
Biography Updated on 4 September 2012